# Black Marble Capital Management

> Black Marble Capital Management is a VC fund backing Medical and Biotechnology. See 11 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 11
- Last investment: Jul 2023
- Lead investor: 0%
- Last updated: Aug 2026

Black Marble Capital Management is a VC fund focused on Medical and Biotechnology. Black Marble Capital Management

## Round sizes

| Stage | Round size |
| --- | --- |
| Series C | $14M–$21M |
| Venture - Series Unknown | $2.8M–$21M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 27% |
| Biotechnology | 3 | 27% |
| Artificial Intelligence | 3 | 27% |
| Software | 2 | 18% |
| Manufacturing | 2 | 18% |

28 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 5 | 45% |
| Series C | 2 | 18% |
| Venture - Series Unknown | 2 | 18% |
| Series A | 1 | 9% |
| Series B | 1 | 9% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Taiwan | 8 | 73% |
| Singapore | 1 | 9% |
| United States | 1 | 9% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AnnJi Pharmaceutical | AnnJi Pharmaceutical is a clinical-stage drug development company that specializes in developing small molecules that address unmet medical needs in the areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy’s disease, and SBMA (Spinal and bulbar muscular atrophy). Thefocus of the company is on creating global collaborations and business partnerships in the late-stage product development and commercialization of pharmaceutical drugs. | $21.1M | Venture - Series Unknown | Jul 05, 2023 |  |
| AIxMed | AIxMed helps pathologists to digitize 3D cytology samples in minutes and extract clinical insights in seconds. The company was founded in 2018 and is headquartered in Santa Clara, California, United States. | $2.8M | Venture - Series Unknown | Apr 27, 2023 |  |
| AnHorn Medicines | AnHorn Medicines is a drug discovery company that develops therapeutic medicines for cancer, neurodegeneration, and aging diseases. | $10M | Series A | Apr 25, 2023 |  |
| Uniconn Interconnections Technology | UNICONN Interconnections Technology provides interconnect solutions for semiconductor wafer testing and vertical probe card applications. |  | Seed | Jan 01, 2023 |  |
| Chip-GaN Power Semiconductor | Chip-GaN Power Semiconductor specializes in power management semiconductors, providing third-generation driver ICs and power management ICs. |  | Seed | Jan 01, 2023 |  |
| CloudMile | CloudMile, a leading AI and cloud technology company in Asia, focuses on digital transformation for its corporate clients and driving growth. Leveraging machine learning and big data analysis, CloudMile assists over 400 clients corporates with business forecasts and industrial upgrades. CloudMile has earned 120+ accreditations, with 60+ GoogleCloud professional certifications. Being the Premier Partner of Google Cloud, CloudMile is qualified for Machine Learning Specialization, Data Analytics Specialization, Cloud Migration Specialization and Infrastructure Specialization. In 2020, CloudMile becomes Taiwan's first Google Cloud Managed Service Provider (MSP) and the winner of Google Cloud Public Sector Partner of the Year in the APAC region. | $14M | Series C | Mar 02, 2022 |  |
| Lejia Regenerative Technology Co. | Lejia Regenerative Technology Co. focuses on the manufacturing of cell and gene therapy products. |  | Seed | Jan 01, 2022 |  |
| XREX | XREX is a neo-fintech leveling the playing field by partnering with banks, regulators, and verified individuals to redefine banking together. Our blockchain-driven solutions create a collective financial system that empowers all to participate and contribute to the global economy. Founded in 2018 and headquartered in Taipei, XREX comprises a teamof world-leading experts in cybersecurity, fintech, compliance, and cryptocurrency to offer a full suite of innovative products such as BitCheck, XREX Circles, Risk Level Detector to solve the dollar-liquidity shortage issues faced by cross-border merchants in emerging economies. | $17M | Seed | Apr 20, 2021 |  |
| Formosa Pharmaceuticals | Formosa Pharmaceuticals is a biopharmaceutical firm that specializes in ophthalmology and oncology. | $21.2M | Series C | Apr 16, 2021 |  |
| CloudMile | CloudMile, a leading AI and cloud technology company in Asia, focuses on digital transformation for its corporate clients and driving growth. Leveraging machine learning and big data analysis, CloudMile assists over 400 clients corporates with business forecasts and industrial upgrades. CloudMile has earned 120+ accreditations, with 60+ GoogleCloud professional certifications. Being the Premier Partner of Google Cloud, CloudMile is qualified for Machine Learning Specialization, Data Analytics Specialization, Cloud Migration Specialization and Infrastructure Specialization. In 2020, CloudMile becomes Taiwan's first Google Cloud Managed Service Provider (MSP) and the winner of Google Cloud Public Sector Partner of the Year in the APAC region. | $10M | Series B | Sep 30, 2020 |  |

10 of 11 investments shown.

## Co-investors
- [ITIC: Industrial Technology Investment Corporation](https://shizune.co/investors/profile/industrial-technology-investment-corporation) — VC Fund, 3 deals together
- [Cathay Venture](https://shizune.co/investors/profile/cathay-venture) — VC Fund, 2 deals together
- [CDIB Capital](https://shizune.co/investors/profile/cdib-capital) — VC Fund, 2 deals together
- [AppWorks](https://shizune.co/investors/profile/appworks-ventures) — VC Fund, 1 deal together
- [Blackwood Capital](https://shizune.co/investors/profile/blackwood-capital) — VC Fund, 1 deal together
- [Cathay Financial Holding](https://shizune.co/investors/profile/cathay-financial-holding-co-ltd) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [National Development Fund of Taiwan Government](https://shizune.co/investors/profile/national-development-fund-of-taiwan-government) — VC Fund
- [Darwin Venture Management](https://shizune.co/investors/profile/darwin-venture-management) — VC Fund
- [AVA Angels](https://shizune.co/investors/profile/ava-angels) — VC Fund

## Featured in investor lists
- [All Investors in Taiwan](https://shizune.co/investors/investors-taiwan)
- [All VC Funds in Taiwan](https://shizune.co/investors/vc-funds-taiwan)
- [Enterprise Investors in Taiwan](https://shizune.co/investors/enterprise-investors-taiwan)
- [Enterprise VC Funds in Taiwan](https://shizune.co/investors/enterprise-vc-funds-taiwan)
- [Climate Investors in Taiwan](https://shizune.co/investors/climate-investors-taiwan)
- [Climate VC Funds in Taiwan](https://shizune.co/investors/climate-vc-funds-taiwan)

## FAQ

### What does Black Marble Capital Management invest in?

Black Marble Capital Management invests primarily in Medical, Biotechnology and Artificial Intelligence startups, most often at Seed and Series C stage. Most of the 11 investments tracked by Shizune back companies in Taiwan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Black Marble Capital Management's check size?

Black Marble Capital Management typically joins rounds of $14M–$21M at Series C and $2.8M–$21M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Black Marble Capital Management participates in.

### When did Black Marble Capital Management last invest?

The most recent investment recorded for Black Marble Capital Management closed in Jul 2023. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co